ADAMANTANE AND PROTOADAMANTANEALKANAMINES AS POTENTIAL ANTI-PARKINSON AGENTS .10.

被引：31

作者：

CHAKRABARTI, JK ^{[1
]}

HOTTEN, TM ^{[1
]}

SUTTON, S ^{[1
]}

TUPPER, DE ^{[1
]}

机构：

[1] LILLY RES CTR LTD,WINDLESHAM,SURREY,ENGLAND

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1976年 / 19卷 / 07期

关键词：

D O I：

10.1021/jm00229a022

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：967 / 969

页数：3

共 14 条

[1]

BARBEAU A, 1971, CAN MED ASSOC J, V105, P42

[2] CHEMISTRY OF ADAMANTANE .7. ADAMANTANE-ALKANAMINES AS POTENTIAL ANTIDEPRESSANT AND ANTI-PARKINSON AGENTS [J].

CHAKRABA.JK ;

FOULIS, MJ ;

HOTTEN, TM ;

SZINAI, SS ;

TODD, A .

JOURNAL OF MEDICINAL CHEMISTRY, 1974, 17 (06) :602-609

[3]

CHAKRABARTI JK, 1975, TETRAHEDRON LETT, P2241

[4]

CHAKRABARTI JK, TO BE PUBLISHED

[5] DOPAMINE AND NORADRENALINE RELEASING ACTION OF AMANTADINE IN CENTRAL AND PERIPHERAL NERVOUS SYSTEM - POSSIBLE MODE OF ACTION IN PARKINSON'S DISEASE [J].

FARNEBO, LO ;

FUXE, K ;

GOLDSTEIN, M ;

HAMBERGER, B ;

UNGERSTEDT, U .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1971, 16 (01) :27-+

[6] EVALUATION OF AMANTADINE AS A RELEASING AGENT OR UPTAKE BLOCKER FOR H3-DOPAMINE IN RAT-BRAIN SLICES [J].

HEIKKILA, RE ;

COHEN, G .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1972, 20 (02) :156-&

[7] PHARMACEUTICAL ASPECTS OF RESERPINE [J].

LEYDEN, AF ;

POMERANTZ, E ;

BOUCHARD, EF .

JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1956, 45 (12) :771-775

[8] FUNCTIONALIZATION AND CLEAVAGE OF ADAMANTANE WITH LEAD TETRA-ACETATE - FORMATION OF 2(3-!4)ABEO-ADAMANTANE FROM ADAMANTANE [J].

LUNN, WHW .

JOURNAL OF THE CHEMICAL SOCIETY C-ORGANIC, 1970, (16) :2124-&

[9] ADAMANTANE CHEMISTRY .I. SYNTHESIS OF 1,2-DISUBSTITUTED ADAMANTANES [J].

LUNN, WHW ;

PODMORE, WD ;

SZINAI, SS .

JOURNAL OF THE CHEMICAL SOCIETY C-ORGANIC, 1968, (13) :1657-&

[10] PHARMACOLOGICAL EFFECTS OF 1,3-DIMETHYL-5-AMINOADAMANTANE, A NEW ADAMANTANE DERIVATIVE [J].

MAJ, J ;

SOWINSKA, H ;

BARAN, L ;

SARNEK, J .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1974, 26 (01) :9-14

← 1 2 →